Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.58 |
| ▸ | TSHR | P16473 | 5/20 | 0.57 |
| ▸ | LMNA | P02545 | 2/20 | 0.57 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.57 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.57 |
| ▸ | DGKA | P23743 | 1/20 | 0.56 |
| ▸ | PAM | P19021 | 2/20 | 0.50 |
| ▸ | NPC1 | O15118 | 1/20 | 0.50 |
| ▸ | GPR84 | Q9NQS5 | 4/20 | 0.48 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.48 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.48 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.47 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.47 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.47 |
| ▸ | PPARG | P37231 | 5/20 | 0.46 |
| ▸ | PPARD | Q03181 | 5/20 | 0.46 |
| ▸ | PPARA | Q07869 | 5/20 | 0.46 |
| ▸ | HDAC11 | Q96DB2 | 4/20 | 0.46 |
| ▸ | TLR2 | O60603 | 2/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3271708 | 1.00 | ALDH1A1 (0.58) | ALDH1A1TSHRLMNANFKB1PMP22 | |
| SCHEMBL7060947 | 1.00 | ALDH1A1 (0.58) | ALDH1A1TSHRLMNANFKB1PMP22 | |
| SCHEMBL7060027 | 1.00 | ALDH1A1 (0.58) | ALDH1A1TSHRLMNANFKB1PMP22 | |
| SCHEMBL1505824 | 1.00 | ALDH1A1 (0.58) | ALDH1A1TSHRLMNANFKB1PMP22 | |
| SCHEMBL7057890 | 1.00 | ALDH1A1 (0.58) | ALDH1A1TSHRLMNANFKB1PMP22 | |
| SCHEMBL3271705 | 1.00 | ALDH1A1 (0.58) | ALDH1A1TSHRLMNANFKB1PMP22 | |
| SCHEMBL7055904 | 1.00 | ALDH1A1 (0.58) | ALDH1A1TSHRLMNANFKB1PMP22 | |
| SCHEMBL7053726 | 1.00 | ALDH1A1 (0.58) | ALDH1A1TSHRLMNANFKB1PMP22 | |
| SCHEMBL7057407 | 1.00 | ALDH1A1 (0.58) | ALDH1A1TSHRLMNANFKB1PMP22 | |
| SCHEMBL1498094 | 1.00 | ALDH1A1 (0.58) | ALDH1A1TSHRLMNANFKB1PMP22 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109152714-B | Cosmetic composition comprising a water-soluble dye | 欧莱雅 | 2024-07-05 | — | — | CN | claimed |
| EP-3558222-B1 | WATER-IN-OIL EMULSION COMPRISING A PARTICULAR EMULSIFYING SYSTEM, A LIPOPHILIC CLAY, AND AN ORGANOPOLYSILOXANE ELASTOMER POWDER COATED WITH A SILICONE RESIN | OREAL (FR) | 2024-04-03 | — | — | EP | claimed |
| CN-116036103-A | Compound hydroquinone emulsion, and preparation method and application thereof | 广东人人康药业有限公司 | 2023-05-02 | — | — | CN | claimed |
| EP-2088988-B1 | SKIN PROTECTIVE MEDIUM, IN PARTICULAR COLD PROTECTIVE CREAM | DEB IP LTD (GB) | 2016-06-01 | — | — | EP | claimed |
| CN-116785317-A | Amphiphilic silicone composition for efficiently removing scars, and preparation method and application thereof | 北京渼颜空间生物医药有限公司 | 2023-09-22 | — | — | CN | disclosed |
| CN-116036103-A | Compound hydroquinone emulsion, and preparation method and application thereof | 广东人人康药业有限公司 | 2023-05-02 | — | — | CN | disclosed |
| US-11369559-B2 | Process for treating keratin substances using a composition comprising a modified photo-dimerizable polymer | L'OREAL (FR) | 2022-06-28 | — | — | US | disclosed |
| US-20190000743-A1 | A PROCESS FOR TREATING KERATIN SUBSTANCES USING A COMPOSITION COMPRISING A MODIFIED PHOTO-DIMERIZABLE POLYMER | L'OREAL (FR) | 2019-01-03 | — | — | US | disclosed |
| EP-3238694-A1 | SUNSCREEN PRODUCT COMPRISING HYDROXYAPATITE AS PHYSICAL FILTER | Kalichem S.r.l. (IT) | 2017-11-01 | — | — | EP | disclosed |
| EP-2410974-B1 | SUNSCREEN COMPOSITION COMPRISING HYDROXYAPATITE AS PHYSICAL SOLAR FILTER | KALICHEM ITALIA S R L (IT) | 2017-05-24 | — | — | EP | disclosed |
| US-9138394-B2 | Pharmaceutical, dermatological, nutritional or cosmetic composition for combating the immunosuppresive action of aggressive agents on the skin | GIULIANI S.P.A. (IT) | 2015-09-22 | — | — | US | disclosed |
| WO-2013190130-A1 | ANHYDROUS COSMETIC COMPOSITION COMPRISING AN OIL, HYDROPHOBIC SILICA AEROGEL PARTICLES, A HYDROPHILIC ACTIVE AGENT AND AT LEAST ONE SURFACTANT | L'OREAL (FR) | 2013-12-27 | — | — | WO | disclosed |
| US-8540972-B2 | Sunscreen product comprising hydroxyapatite as physical filter | KALICHEM ITALIA S.R.L. (IT) | 2013-09-24 | — | — | US | disclosed |
| US-20120020902-A1 | PHARMACEUTICAL, DERMATOLOGICAL, NUTRITIONAL OR COSMETIC COMPOSITION FOR COMBATING THE IMMUNOSUPPRESSIVE ACTION OF AGGRESSIVE AGENTS ON THE SKIN | GIULIANI S.P.A. (IT) | 2012-01-26 | — | — | US | disclosed |
| US-20120014891-A1 | SUNSCREEN PRODUCT COMPRISING HYDROXYAPATITE AS PHYSICAL FILTER | KALICHEM ITALIA S.R.L. (IT) | 2012-01-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190000743-A1 | A PROCESS FOR TREATING KERATIN SUBSTANCES USING A COMPOSITION COMPRISING A MODIFIED PHOTO-DIMERIZABLE POLYMER | KRT18, KRTCAP2, CKAP4 | ALDH1A1 1833/4885TSHR 3731/4885LMNA 622/4885 |
| US-20120020902-A1 | PHARMACEUTICAL, DERMATOLOGICAL, NUTRITIONAL OR COSMETIC COMPOSITION FOR COMBATING THE IMMUNOSUPPRESSIVE ACTION OF AGGRESSIVE AGENTS ON THE SKIN | TP53, DSG1, FOXM1 | ALDH1A1 2521/4885TSHR 4190/4885LMNA 4837/4885 |
| US-11369559-B2 | Process for treating keratin substances using a composition comprising a modified photo-dimerizable polymer | KRT18, KRTCAP2, CKAP4 | ALDH1A1 2099/4885TSHR 3882/4885LMNA 622/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.